Measles became a bigger ‘threat’ to the world while it was focused on Covid-19

Nearly 40 million children missed at least one measles vaccine dose in 2021.

Michael Head, The Conversation

· Dec 09, 2022 · 11:30 pm

Monkeypox: Everthing you need to know about the viral outbreak in Europe and UK

Patients typically develop a fever, a distinctive rash and blisters.

Michael Head, The Conversation

· May 20, 2022 · 07:30 pm

In North Korea, Covid-19 is threatening a humanitarian catastrophe

The country, which has a population of roughly 2.6 crore people, may be facing a very sizeable and rapidly-spreading outbreak of the Omicron variant.

Michael Head, The Conversation

· May 18, 2022 · 09:30 pm

After India, which countries could see a big rise in Covid-19 cases?

The next outbreak may prove difficult to spot. But it will be a result of a slow vaccine rollout and susceptible populations mixing freely.

Michael Head, The Conversation

· May 25, 2021 · 01:30 pm

From US to EU, the Oxford-AstraZeneca vaccine is having a rollercoaster ride

Whatever the setbacks, the latest phase 3 trial data from the US provide further evidence that the vaccine is safe and that it works in older people.

Michael Head, The Conversation

· Mar 25, 2021 · 09:30 pm

Oxford AstraZeneca vaccine is a global game-changer even with 70% efficiency in initial trials

Despite the vaccine having lower overall effectiveness than the Pfizer or Moderna candidates, there are other success factors to consider.

Michael Head, The Conversation

· Nov 24, 2020 · 09:30 pm